Noninvasive detection of acute heart rejection: the quest for the perfect test

Editorial

M Ballester et al. J Nucl Cardiol. 1997 May-Jun.

. 1997 May-Jun;4(3):249-55.

doi: 10.1016/s1071-3581(97)90087-8.

No abstract available

Similar articles

Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
Ballester M, Bordes R, Tazelaar HD, Carrió I, Marrugat J, Narula J, Billingham ME. Ballester M, et al. J Am Coll Cardiol. 1998 May;31(6):1357-61. doi: 10.1016/s0735-1097(98)00084-9. J Am Coll Cardiol. 1998. PMID: 9581733
Detection of human cardiac transplant rejection with indium-111 monoclonal antimyosin antibody imaging.
Crespo MG, Pulpón LA, Domínguez P, Chamorro JL, Argüeso MJ, Pradas G, García M, Segovia J, Figuera D. Crespo MG, et al. Transplant Proc. 1990 Aug;22(4):1463. Transplant Proc. 1990. PMID: 2389365 No abstract available.
Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.
Frist W, Yasuda T, Segall G, Khaw BA, Strauss HW, Gold H, Stinson E, Oyer P, Baldwin J, Billingham M, et al. Frist W, et al. Circulation. 1987 Nov;76(5 Pt 2):V81-5. Circulation. 1987. PMID: 3311460
Antimyosin antibodies in cardiac rejection.
Schütz A, Breuer M, Kemkes BM. Schütz A, et al. Ann Thorac Surg. 1997 Feb;63(2):578-81. doi: 10.1016/s0003-4975(96)01106-x. Ann Thorac Surg. 1997. PMID: 9033354 Review.
Monoclonal Fab antimyosin in cardiac imaging.
Johnson LL. Johnson LL. Clin Cardiol. 1992 Mar;15(3):145-53. doi: 10.1002/clc.4960150304. Clin Cardiol. 1992. PMID: 1551261 Review.

Cellular and molecular basis of inflammatory myocardial disease.
Barry WH. Barry WH. J Nucl Cardiol. 2001 Jul-Aug;8(4):499-505. doi: 10.1067/mnc.2001.116166. J Nucl Cardiol. 2001. PMID: 11481572 Review. No abstract available.